Sign In
Buy COR
$306.28
-2.09 (-0.678%)
At Close: Aug 04, 2026
Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release
07:30am, Wednesday, 08'th Jan 2025
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the First Quarter of Fiscal 2025 on Wednesday, February 5, 2025, prior to the ope
Cencora Stock May Gain Following the Strategic Acquisition of RCA
10:46am, Friday, 03'rd Jan 2025
COR completes the acquisition of Retina Consultants of America, marking a significant step in expanding its specialty healthcare and MSO solutions.
Cencora raises annual profit forecast
04:23pm, Thursday, 02'nd Jan 2025
Drug distributor Cencora raised its annual adjusted profit forecast on Thursday.
Cencora Completes Acquisition of Retina Consultants of America
04:15pm, Thursday, 02'nd Jan 2025
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the completion of its previously announced acquisition of Retina Consultants of America (“RCA”), a leading management
Cencora (COR) Upgraded to Buy: Here's What You Should Know
01:15pm, Wednesday, 01'st Jan 2025
Cencora (COR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Here's Why Cencora (COR) is a Strong Growth Stock
10:51am, Wednesday, 01'st Jan 2025
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Cencora (COR) is a Top Value Stock for the Long-Term
10:40am, Tuesday, 31'st Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Is the Options Market Predicting a Spike in Cencora (COR) Stock?
09:25am, Tuesday, 31'st Dec 2024
Investors need to pay close attention to Cencora (COR) stock based on the movements in the options market lately.
Why Cencora (COR) is a Top Growth Stock for the Long-Term
10:46am, Monday, 16'th Dec 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here's Why You Should Hold Cencora Stock in Your Portfolio for Now
08:55am, Friday, 13'th Dec 2024
COR continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
Here's Why Cencora (COR) is a Strong Value Stock
10:41am, Thursday, 12'th Dec 2024
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Nittetsu Mining Provides $1.5 Million Fourth Earn-in Payment for Upcoming Drilling Campaign at Camino's Los Chapitos Project
06:00am, Thursday, 12'th Dec 2024
VANCOUVER, BC / ACCESSWIRE / December 12, 2024 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce the receipt of CAD$1.5 million from explorati
Cencora Closes $1.8 Billion Senior Notes Offering
04:15pm, Monday, 09'th Dec 2024
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced the closing of its public offering of $500,000,000 aggregate principal amount of its 4.625% Senior Notes due December 15,
Cencora Launches Accelerate Pharmacy Solutions to Enhance Support for Hospital and Health System Customers
08:30am, Friday, 06'th Dec 2024
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, a global healthcare company, announced the launch of Accelerate Pharmacy Solutions, a unified portfolio of solutions designed to help hospital and health s
Cencora: Competitive Advantages Defined
10:26am, Thursday, 05'th Dec 2024
Cencora is a 'super cash cow' with high capital turnover and low margins, generating substantial free cash flow from its competitive advantages. COR's business model thrives on low-cost operations, en
